Worth reading
63In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 16 April 2026Incoming appointee
3 itemsScheduled Appointment Date27 May 2026 (scheduled to be formally decided following the 54th Annual General Meeting of Shareholders and the Board of Directors meeting to be held after it on the same day)
Inoue Junko (井上 純子)
Previous positionRepresentative Director and Executive Vice President
New positionRepresentative Director and President
生年月日 16 November 1967入社年 2022所有株式数 359,656 shares (record date: Not disclosed)
Ito Shinichi (伊藤 真市)
Previous positionUntil September 2024, Managing Director and General Manager of the Administration Division of the Company (retired in September 2024)
New positionDirector (details of responsibilities and position: Not disclosed)
生年月日 2 April 1959入社年 2004所有株式数 20,000 shares (record date: Not disclosed)
Inoue Nanami (井上 奈奈美)
Previous positionJoined the Company and assigned to the Sales Department (current)
New positionDirector (details of responsibilities and position: Not disclosed)
生年月日 10 May 2000入社年 2021所有株式数 40,000 shares (record date: Not disclosed)
Departing officer
1 itemDate of departure27 May 2026
Inoue Yoshiyuki (井上 善行)Next role stated
Former PositionRepresentative Director and President
New positionChair (no longer a director)
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Reason for departure
Requires long-term medical treatment due to illness
Whether the incumbent will remain in office (whether they will retain their position)
Will not remain on the Board of Directors (will become Chair)
Directors after the change9Number
Shareholders’ meeting approvalYes. The proposal for the election of director candidates at the 54th Annual General Meeting of Shareholders, scheduled for 27 May 2026
Reason for change
The Company will establish a new management structure because Representative Director Inoue Yoshiyuki (井上 善行) requires long-term medical treatment due to illness.
| Item | Details |
|---|---|
| Resolution date | 16 April 2026 |
| Scheduled Appointment Date | 27 May 2026 (scheduled to be formally decided following the 54th Annual General Meeting of Shareholders and the Board of Directors meeting to be held after it on the same day) |
| Date of departure | 27 May 2026 |
| Name of appointee | Inoue Junko (井上 純子), Ito Shinichi (伊藤 真市), Inoue Nanami (井上 奈奈美) |
| Appointee's new position | Representative Director and President, Director (details of responsibilities and position: Not disclosed), Director (details of responsibilities and position: Not disclosed) |
| Appointee's previous position | Representative Director and Executive Vice President, Until September 2024, Managing Director and General Manager of the Administration Division of the Company (retired in September 2024), Joined the Company and assigned to the Sales Department (current) |
| Appointee's date of birth | 16 November 1967, 2 April 1959, 10 May 2000 |
| Year the appointee joined the Company | 2022, 2004, 2021 |
| Number of shares held by the appointee | 359,656 shares (record date: Not disclosed), 20,000 shares (record date: Not disclosed), 40,000 shares (record date: Not disclosed) |
| Name of departing officer | Inoue Yoshiyuki (井上 善行) |
| Former position of departing officer | Representative Director and President |
| New position of departing officer | Chair (no longer a director) |
| Reason for departure | Requires long-term medical treatment due to illness |
| Whether the incumbent will remain in office | Will not remain on the Board of Directors (will become Chair) |
| Reason for change | The Company will establish a new management structure because Representative Director Inoue Yoshiyuki (井上 善行) requires long-term medical treatment due to illness. |
| Number of directors after the change | 9 directors, including 3 outside directors |
| Subject to Approval by the General Meeting of Shareholders | Yes. The proposal for the election of director candidates at the 54th Annual General Meeting of Shareholders, scheduled for 27 May 2026 |
Items this document does not state (4)
Reasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company will establish a new management structure because Representative Director Inoue Yoshiyuki (井上 善行) requires long-term medical treatment due to illness.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.